Navigation Links
Lilly Announces Major Donation of Insulin to International Diabetes Federation's Life for a Child Program; Initial Focus Will Be on Sub-Saharan Africa
Date:11/12/2008

Donation of more than 800,000 insulin vials to provide free life-saving

medicine to an estimated 24,000 children over four years

INDIANAPOLIS, Nov. 12 /PRNewswire-FirstCall/ -- Eli Lilly and Company today announced it intends to donate more than 800,000 vials of insulin to the International Diabetes Federation's Life for a Child Program, providing free life-saving medicine to as many as 24,000 children who currently have no access to diabetes treatment.

The initial focus of the donations will be to help children with diabetes in sub-Saharan Africa. This donation will allow the International Diabetes Federation (IDF) to expand its work meaningfully over the next four years in at least nine of the poorest countries on the continent.

Lilly's donation is the largest corporate insulin donation to the Life for a Child Program and one of Lilly's largest single contributions of free insulin in the 85 years since the company introduced the world's first mass-produced insulin in 1923.

Lilly made the announcement at this time to commemorate the theme of this year's World Diabetes Day (November 14) -- diabetes in children and adolescents.

"Diabetes is emerging as one of the most serious health problems of our time, and children with diabetes in the developing world are particularly vulnerable," said Dr. Carlos Paya, vice president, Lilly Research Laboratories and leader of Lilly's Global Diabetes and Endocrine Platform. "For nearly nine decades, Lilly has been at the forefront of providing solutions to combat the problems of diabetes around the world, and there is no more dire need right now than to ensure children with diabetes in the developing world - particularly sub-Saharan Africa - have access to the insulin they need to stay alive. We are committed to working with IDF to help these children survive."

The Life for a Child Program provides access to care, education and life-saving medicines and supplies to support
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Robert J. Heine, M.D., Ph.D., F.R.C.P. to Join Lilly; Distinguished Diabetes Expert to Lead Diabetes/Endocrine Medical Division
3. Lauren Marangell, M.D. to Join Lilly; Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar
4. Genentech/Roches Lucentis and Eli Lillys Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets
5. Lillys CEO Calls for Reform of Nations Drug Safety System
6. Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
7. Lilly Grant to VA Will Enhance Services for Returning Combat Veterans
8. Lilly Delivers Strong Third-Quarter Results
9. Lilly and MacroGenics Announce Licensing and Collaboration Agreement
10. Eli Lilly and Company Aids California Recovery Effort
11. Eli Lilly and Company Announces 2007 Lilly Reintegration Awards Recipients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., KELOWNA, BC, Nov. 27 /PRNewswire/ - Uploadable U...ng prime time in wellness. A combination of advanc...upload are solving a long term concern over the ac... accurately gauge and reward improved participatio...ies is one of the first wellness suppliers to inte...
(Date:11/27/2009)..., SAN FRANCISCO, Nov. 27 ...ed that Blair Lambert, CFO/COO, will present at th...held at the May Fair Hotel in London, England, on ..., To listen to a live broadcast of The Gymboree ...se log on to www.gymboree.com, click on "Our Compa...
(Date:11/27/2009)..., KIBBUTZ SHAMIR, Israel, Nov. 27 /PRNewswire-Firs...HMR ) ( "Shamir" ), a leading provider of innovati...market, announced today that its board of director...gate amount of US$ 10 million (approximately NIS 3...entative rate of exchange), or approximately US$ 0...
(Date:11/27/2009)...ates to bring unprecedented medical, economic burd...(HealthDay News) -- The number of people with diab...er the next 25 years, a new study predicts. , T...llion people with the disease, up from 23.7 millio...ing people with diabetes will triple, the study al...
(Date:11/27/2009)... Multi-purpose bilingual coloring ... for use by the business community to educate - in...bjects from Safety issues to Dinosuars to ABC,S an... Saint Louis, MO (PRWEB) November 27, 2009 -- To...ics or toys to keep them busy any hour of the day,...
Breaking Medicine News(10 mins):Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2
...e for its smartTOUCH(R),product line, JERICHO, N....RX) today announced that it has signed a three yea...andyman service, Mr.,Handyman, to provide its cust...rmostats, mailboxes and more., "As our company in...
...reatment Cleared for,Patients Who Have Not Benefit...Pa., Oct. 8 Neuronetics, Inc., a,privately-held m...,neuromodulation, announced today that the U.S. Fo...roStar TMS Therapy(R) is,specifically indicated fo...
...w.ilcdover.com ),the company that manufactures spa...premium line of aesthetically pleasing head covers...roduct is the direct result,of feedback from healt...bin/prnh/20081008/NEW027 ), The new printed head...
..., but all,the money you,re spending on gifts for f...erry. Don,t let yourself fall into the trap of hol...gation. Take the following,simple measures to prev...ck it twice -- planning a realistic budget ahead,o...
...sociation (DIA) will host the 6th Canadian Annual ... discuss a number of important issues facing Healt...emia, and the health care system. , ...g/diahome/FlagshipMeetings/home.aspx?meetingid=171...
...North America) announced today the extension of it...., a leading nanotechnology co-development company...Business Wire EON) October 7, 2008 -- The origina... materials. , , , After successfully meeting initi...
Other Medicine News:Health News:bioMETRX Teams Up With Mr. Handyman 2Health News:bioMETRX Teams Up With Mr. Handyman 3Health News:FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression 2Health News:FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression 3Health News:FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression 4Health News:FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression 5Health News:ILC Dover Introduces 'Patient Friendly' Respiratory Protection for Health Care Market 2Health News:Holiday Gift Giving: How You and Your Budget can Survive the Season 2Health News:DIA 6th Canadian Annual Meeting Benefit and Risk Management: An Evolution in Progress 2Health News: Merck KGaA and Nano-Terra Announce Extension of Nanotechnology Solutions Alliance 2Health News: Merck KGaA and Nano-Terra Announce Extension of Nanotechnology Solutions Alliance 3
(Date:11/24/2009)...swire/ -- ,, WHAT: Rom Houbens, a Belgian man...ng an auto accident, was actually fully conscious ...a Good Morning America segment. The DynaVox EyeMa...ople with Locked-in Syndrome and other conditions ...g America -- Tuesday, November 24 available onli...
(Date:11/24/2009)...PRNewswire-FirstCall/ -- Quest Diagnostics Incorpo... of diagnostic testing, information and services, ...t Annual Piper Jaffray Healthcare Conference in Ne...dnesday, December 2, 2009 at 9:30 a.m. Eastern Tim...eaffirm its 2009 guidance for revenue growth to ap...
(Date:11/24/2009)...ire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Na... at the 21st Annual Piper Jaffray Healthcare Confe...T (6:00 a.m. PST). The conference is being held a..., President and Chief Executive Officer of Anadys,...al development programs, ANA598 and ANA773. ,, ...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2The Power of Five 3A New OmniFlex Nourishes Joints in Convenient Effective Doses 56112 1The Power of Five 3A New OmniFlex Nourishes Joints in Convenient Effective Doses 56112 2Aging Population Heightened Consumer Awareness Propel U S Bone and Joint Health Ingredients Says Frost 26 Sullivan 56111 1Aging Population Heightened Consumer Awareness Propel U S Bone and Joint Health Ingredients Says Frost 26 Sullivan 56111 2Aging Population Heightened Consumer Awareness Propel U S Bone and Joint Health Ingredients Says Frost 26 Sullivan 56111 3Aging Population Heightened Consumer Awareness Propel U S Bone and Joint Health Ingredients Says Frost 26 Sullivan 56111 4Isis Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference 2009 56108 1Isis Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference 2009 56108 2
...aring Leading Hepatitis C Therapies Provides ...ctice, MILAN, Italy, April 26 Final results of t...cal study comparing the,leading therapies for chro...Annual Meeting of the European Association for the...sights that may help guide clinical practice,for p...
...lcath Systems, Inc.,(Nasdaq: DCTH ) announced tod...e University of Maryland Medical Center (UMMC) has...udy of the Company,s Percutaneous Hepatic,Perfusio...y of the,anti-cancer agent melphalan to treat inop...al, Phase III study is being led by the National C...
Other Medicine Technology:Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 2Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 3Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 4Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 5Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 6Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 7Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 8Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 9Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 10Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center 2Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center 3Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center 4
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: